Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ellen Hanayo Nagami, M.D.

Concepts (111)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hepatitis C5201515910.390 Why?
Syphilis220122270.380 Why?
Hepatitis C, Chronic1201210310.240 Why?
Aminoquinolines120231090.220 Why?
Antiviral Agents2201229870.220 Why?
Babesiosis12023920.200 Why?
Prisoners320132970.180 Why?
Hepacivirus3201313790.170 Why?
Wounds and Injuries1201024000.160 Why?
Cardiology Service, Hospital120192460.150 Why?
AIDS-Related Complex120121110.110 Why?
Patient Admission1201913800.100 Why?
HIV Infections32012167180.100 Why?
Lymphatic Diseases120123240.090 Why?
Genes, MHC Class I120102580.090 Why?
HLA-B Antigens120103530.080 Why?
Academic Medical Centers1201927590.080 Why?
Prisons120101610.080 Why?
AIDS-Related Opportunistic Infections120126570.080 Why?
Ribavirin120093950.080 Why?
Viral Load3201233000.070 Why?
HIV Seropositivity120129710.070 Why?
Interferon-alpha120098950.060 Why?
Antigen Presentation1201012840.060 Why?
Healthcare Disparities1201931580.060 Why?
RNA, Viral2200929020.060 Why?
Histocompatibility Antigens Class I1201013660.060 Why?
Polyethylene Glycols1200911810.060 Why?
Acquired Immunodeficiency Syndrome1201222340.060 Why?
RNA, Ribosomal, 23S12023530.060 Why?
Atovaquone12023580.060 Why?
HIV-12201069380.050 Why?
Health Services Accessibility1201951380.050 Why?
Killer Cells, Natural1201021330.050 Why?
Lymph Nodes1201234690.050 Why?
Acute Disease3201571480.040 Why?
Drug Resistance1202316080.040 Why?
Middle Aged820192133670.040 Why?
Substance-Related Disorders1201342590.040 Why?
Heart Failure12019109050.030 Why?
Anti-Bacterial Agents1201271790.030 Why?
Boston2201993110.030 Why?
Hepatitis C Antibodies120131450.030 Why?
Male820193500270.030 Why?
Tuberculosis, Lymph Node12012190.030 Why?
Mycobacterium avium-intracellulare Infection12012760.030 Why?
Seroepidemiologic Studies120134020.020 Why?
Drug Users120131340.020 Why?
Recurrence1202383430.020 Why?
Treatment Outcome22019631190.020 Why?
HLA-C Antigens120101470.020 Why?
NK Cell Lectin-Like Receptor Subfamily K12010910.020 Why?
HLA-A Antigens120102310.020 Why?
HIV Long-Term Survivors120101260.020 Why?
HIV Antigens120103470.020 Why?
Humans1120237442200.020 Why?
Sarcoma, Kaposi120123700.020 Why?
K562 Cells120106340.020 Why?
Solubility1201010830.020 Why?
Matrix Metalloproteinases120103910.020 Why?
Inpatients1201925180.020 Why?
Health Status Disparities1201917970.020 Why?
Logistic Models22012134090.020 Why?
Viremia120097360.020 Why?
CD4 Lymphocyte Count1201225590.020 Why?
DNA Primers1201028920.020 Why?
Young Adult42015564360.020 Why?
Patient Readmission1201931140.020 Why?
Lymphoma, Non-Hodgkin1201213800.020 Why?
Substance Abuse, Intravenous120095250.020 Why?
Population Surveillance1201526160.020 Why?
Amino Acids1201017340.020 Why?
Program Evaluation1201324860.010 Why?
Haplotypes1201027810.010 Why?
Cohort Studies32012405590.010 Why?
Retrospective Studies32019774260.010 Why?
Ligands1201032940.010 Why?
Down-Regulation1201030010.010 Why?
Protein Conformation1201040120.010 Why?
Massachusetts1201586630.010 Why?
Self Report1201335580.010 Why?
Immune Tolerance1201022580.010 Why?
Adult520152140350.010 Why?
Up-Regulation1201042170.010 Why?
Female620193801970.010 Why?
Models, Molecular1201054580.010 Why?
Biopsy1201267570.010 Why?
Pilot Projects1201383210.010 Why?
Recombinant Proteins1200966120.010 Why?
Risk Factors22019722800.010 Why?
Alleles1201069380.010 Why?
Base Sequence12010128010.010 Why?
Immunity, Innate1201029580.010 Why?
Risk Assessment12019233370.010 Why?
Time Factors12019400630.010 Why?
CD4-Positive T-Lymphocytes1201043850.010 Why?
Mass Screening1201352520.010 Why?
Incidence12015209450.010 Why?
CD8-Positive T-Lymphocytes1201044770.010 Why?
Transcription, Genetic1201077230.010 Why?
Cell Line12010159990.010 Why?
Genotype12009129560.010 Why?
Adolescent22015857590.010 Why?
Aged, 80 and over12019577680.010 Why?
Disease Progression12010132800.010 Why?
Case-Control Studies12010217520.010 Why?
Cross-Sectional Studies12013250430.010 Why?
Genome-Wide Association Study12010122640.010 Why?
Polymorphism, Single Nucleotide12010155250.010 Why?
United States12015698670.000 Why?
Aged120191632530.000 Why?
Nagami's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (111)
Explore
_
Co-Authors (88)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.